Position in PFE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$242,365
-$80,835 QoQ
Shares Held
10,065
-12.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,299
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MV CAPITAL MANAGEMENT, INC. holds $82,370,025 across 15 Drug Manufacturers - General names. PFE ranks #7 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
271,250 | $68,257,350 | |
| 2 | JNJ |
Johnson & Johnson
|
14,678 | $3,727,771 | |
| 3 | AMGN |
Amgen Inc
|
8,630 | $3,125,095 | |
| 4 | LLY |
ELI LILLY & Co
|
2,477 | $2,970,988 | |
| 5 | MRK |
Merck & Co., Inc.
|
22,792 | $2,928,772 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,582 | $957,909 | |
| 7 | PFE |
Pfizer Inc
This page
|
10,065 | $242,365 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,153 | $66,435 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,365 | 10,065 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $323,200 | 11,510 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $286,673 | 11,513 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $255,054 | 10,010 | Shares | Sole | 2026-02-23 | |
| 2025-06-30 | $209,821 | 8,656 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $124,242 | 4,903 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $177,459 | 6,689 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $209,930 | 7,254 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $191,383 | 6,840 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $160,395 | 5,780 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $776,207 | 26,961 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $1,766,103 | 53,244 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,931,275 | 52,652 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,008,828 | 49,236 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $2,513,270 | 49,049 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $2,080,131 | 47,535 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $2,405,121 | 45,873 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $2,334,361 | 45,091 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,645,440 | 44,800 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,867,236 | 43,414 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,603,445 | 40,946 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,414,274 | 39,036 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,146,594 | 31,149 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $983,559 | 26,800 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $736,110 | 22,511 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $553,149 | 16,947 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||